Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate effect on propofol target-controlled infusion concentration
ChiCTR1900026826Phase 4Not yet recruiting
- Sponsor
- People's Hospital of Kizilsu Kirghiz Autonomous Prefecture
- Start
- Oct 2109
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of magnesium sulfate and propofol in cholelithiasis (3 arms), sponsored by People's Hospital of Kizilsu Kirghiz Autonomous Prefecture. Primary endpoint: Effective concentration for 50%. Planned start Oct 2109; status: not yet recruiting.
02
Drugs
magnesium sulfatepropofol
03
Conditions
cholelithiasis
Beyond the preview
Go deeper on ChiCTR1900026826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026826.